[Sublingual buprenorphine in the treatment of pain caused by cancer. Transition to buprenorphine from other opiates].
D000328:Adult; D000368:Aged; D000701:Analgesics, Opioid / Q000008:administration & dosage; D002047:Buprenorphine / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008614:Meperidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D008875:Middle Aged; D009019:Morphinans / Q000627:therapeutic use*; D009022:Morphine Derivatives / Q000008:administration & dosage; D009369:Neoplasms / Q000150:complications; D010148:Intractable Pain / Q000188:drug therapy* / Q000209:etiology; D010166:Palliative Care
D000701:Analgesics, Opioid; D009019:Morphinans; D009022:Morphine Derivatives; D002047:Buprenorphine; D008614:Meperidine; C012394:ketobemidone
Sublingval buprenorfin i behandlingen af cancersmerter. Overgang til buprenorfin fra andet opiat.